Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Published in: Annals of Surgical Oncology 1/2020

01-01-2020 | Burnout Syndrome | Translational Research and Biomarkers

Translation of Patient-Reported Outcomes in Oncology Clinical Trials to Everyday Practice

Authors: Srinivas Joga Ivatury, MD, MHA, FACS, FASCRS, Hannah W. Hazard-Jenkins, MD, FACS, Gabriel A. Brooks, MD, MPH, Nadine J. McCleary, MD, MPH, Sandra L. Wong, MD, MS, FACS, Deborah Schrag, MD, MPH

Published in: Annals of Surgical Oncology | Issue 1/2020

Login to get access

Abstract

Purpose

Clinical trials in oncology evaluating the effects of patient-reported outcomes (PRO) collection have found that monitoring of symptoms with PROs is associated with improved clinical care through reduced acute care utilization and decreased patient symptom burden. This educational review will evaluate strategies for systematic PRO integration into everyday oncology clinical practice.

Methods

We outline key considerations for using PROs in clinical practice, highlighting evidence from published studies. We also discuss the benefits and challenges of PRO implementation in oncology.

Results

Implementing PRO collection in clinical practice can improve care delivery and facilitate patient-centered clinical research. Considerations for using PROs in clinical practice include choice of instrument, method of delivery, and frequency of query. Challenges with implementing systematic PRO collection include the costs and resources needed for implementation, impact on clinical workflow, and controlling/monitoring physician burnout.

Conclusions

While challenges exist in terms of financial resources and staff participation/burnout, patient-reported outcomes in clinical practice provide a number of benefits, including symptom monitoring, clinical research, and potential real-time personalized clinical-decision support.
Literature
1.
U.S. Food and Drug Administration. Guidance for Industry. Patient-reported outcome measures: use in medical product development to support labeling claims. Federal Register 2009;74(35):65132–13.
2.
Velikova G, Velikova G, BoothL, Smith AB, Brown PM, Lynch P, Brown JM, et al. Measuring quality of life in routine oncology practice improves communication and patient well-being: a randomized controlled trial. J Clin Oncol. 2004;22(4):714–24.CrossRef
3.
Velikova G, Keding A, Harley C, Cocks K, Booth L, Smith AB, et al. Patients report improvements in continuity of care when quality of life assessments are used routinely in oncology practice: secondary outcomes of a randomised controlled trial. Eur J Cancer. 2010;46(13):2381–88.CrossRef
4.
Basch E, Deal AM, Kris MG, Scher HI, Hudis CA, Sabbatini P, et al. Symptom monitoring with patient-reported outcomes during routine cancer treatment: a randomized controlled trial. J Clin Oncol. 2016;34(6):557–65.CrossRef
5.
Basch E, Abernethy AP. Supporting clinical practice decisions with real-time patient-reported outcomes. J Clin Oncol. 2011;29(8):954–6.CrossRef
6.
Boyes A, Newell S, Girgis A, McElduff P, Sanson‐Fisher R. Does routine assessment and real-time feedback improve cancer patients’ psychosocial well-being? Eur J Cancer Care. 2006;15(2):163–71.CrossRef
7.
Snyder CF, Herman JM, White SM, Luber BS, Blackford AL, Carducci MA, et al. When using patient-reported outcomes in clinical practice, the measure matters: a randomized controlled trial. J Oncol Pract. 2014;10(5):e299–306.CrossRef
8.
Klinkhammer-Schalke M, Koller M, Steinger B, Ehret C, Ernst B, Wyatt JC, et al. Direct improvement of quality of life using a tailored quality of life diagnosis and therapy pathway: randomised trial in 200 women with breast cancer. Br J Cancer. 2012;106(5):826–38.CrossRef
9.
10.
Rolstad, S., Adler, J. & Rydén, A., Response burden and questionnaire length: is shorter better? A review and meta-analysis. Value Health J Int Soc Pharm Outcomes Res. 2011;14(8):1101–08.CrossRef
11.
Wei JT, Dunn RL, Litwin MS, Sandler HM, Sanda MG. Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer. Urology. 2000;56(6):899–05.CrossRef
12.
Aaronson N, Elliott T, Greenhalgh J, et al. (eds). User’s guide to implementing patient-reported outcomes assessment in clinical practice version 2. Milwaukee: International Society for Quality of Life Research; 2015.
13.
Gibbons MC, Wilson RF, Samal L, Lehman CU, Dickersin K, Lehmann HP. Impact of consumer health informatics applications. Evidence Rep/Technol Assessment. 2009;188:1–546.
14.
Archer N, Fevrier-Thomas U, Lokker C, McKibbon KA, Straus SE. Personal health records: a scoping review. J Am Med Inf Assoc JAMIA. 2011;18(4):515–22.CrossRef
15.
16.
McCleary NJ, Wigler D, Berry D, et al. Feasibility of computer-based self-administered cancer-specific geriatric assessment in older patients with gastrointestinal malignancy. Oncologist. 2013;18(1):64–72.CrossRef
17.
Heyworth L, Kleinman K, Oddleifson S, Bernstein L, Frampton J, Lehrer M, et al. Comparison of interactive voice response, patient mailing, and mailed registry to encourage screening for osteoporosis: a randomized controlled trial. Osteoporosis Int. 2014;25(5):1519–26.CrossRef
18.
19.
Abernethy AP, Herndon JE, Wheeler JL, Patwardhan M, Shaw H, Lyerly HK, et al. Improving health care efficiency and quality using tablet personal computers to collect research-quality, patient-reported data. Health Serv Res. 2008;43(6):1975–91.CrossRef
20.
21.
22.
Krebs P, Duncan DT. Health app use among US mobile phone owners: a national survey. JMIR mHealth uHealth. 2015;3(4):e101.CrossRef
23.
Weinstein JN, Tosteson TD, Lurie JD, et al. Surgical vs nonoperative treatment for lumbar disk herniation: the Spine Patient Outcomes Research Trial (SPORT): a randomized trial. JAMA. 2006;296(20):2441–50.CrossRef
24.
25.
26.
Colt HG, Murgu SD, Korst RJ, et al. Follow-up and surveillance of the patient with lung cancer after curative-intent therapy: diagnosis and management of lung cancer: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013;143(5):e437S–54S.CrossRef
27.
Sinsky C, Colligan L, Li L, et al. Allocation of physician time in ambulatory practice: a time and motion study in 4 specialties. Ann Internal Med. 2016;165(11):753–60.CrossRef
Metadata
Title
Translation of Patient-Reported Outcomes in Oncology Clinical Trials to Everyday Practice
Authors
Srinivas Joga Ivatury, MD, MHA, FACS, FASCRS
Hannah W. Hazard-Jenkins, MD, FACS
Gabriel A. Brooks, MD, MPH
Nadine J. McCleary, MD, MPH
Sandra L. Wong, MD, MS, FACS
Deborah Schrag, MD, MPH
Publication date
01-01-2020
Publisher
Springer International Publishing
Published in
Annals of Surgical Oncology / Issue 1/2020
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-019-07749-2

Other articles of this Issue 1/2020

Annals of Surgical Oncology 1/2020 Go to the issue

ASO Author Reflections

ASO Author Reflections: Recurrence Patterns After Surgical Treatment of Pseudomyxoma Peritonei From Low-Grade Appendiceal Mucinous Neoplasms

Peritoneal Surface Malignancy

Prognostic Impact of BRAF and KRAS Mutation in Patients with Colorectal and Appendiceal Peritoneal Metastases Scheduled for CRS and HIPEC

Peritoneal Surface Malignancy

Implementation of an Enhanced Recovery After Surgery (ERAS) Program is Associated with Improved Outcomes in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

Health Services Research and Global Oncology

Prioritizing the Patient Perspective in Oncologic Surgery

Peritoneal Surface Malignancy

Desmoplastic Small Round Cell Tumor: Long-Term Complications After Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy

Melanoma

The Sunbelt Melanoma Trial